What is Livecare Corp?
focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
LVCE · Verdict
Moderate reward · moderate risk
LVCE's standout is balance sheet; profitability and volatility weigh on the picture.
Based on 63% data coverage
LVCE · Verdict
Current ratio 2.14
-1430% return on equity
Below average
Model-based scoring. For information only — not financial advice.
focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach. The company is a real-time health, analytics, service, and monitoring company that provides persons with type II diabetes with solutions. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 381.86K.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.